Ince Tan A, Sousa Aurea D, Jones Michelle A, Harrell J Chuck, Agoston Elin S, Krohn Marit, Selfors Laura M, Liu Wenbin, Chen Ken, Yong Mao, Buchwald Peter, Wang Bin, Hale Katherine S, Cohick Evan, Sergent Petra, Witt Abigail, Kozhekbaeva Zhanna, Gao Sizhen, Agoston Agoston T, Merritt Melissa A, Foster Rosemary, Rueda Bo R, Crum Christopher P, Brugge Joan S, Mills Gordon B
Department of Pathology, Interdisciplinary Stem Cell Institute, Braman Family Breast Cancer Institute, and Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27514, USA.
Nat Commun. 2015 Jun 17;6:7419. doi: 10.1038/ncomms8419.
Currently available human tumour cell line panels consist of a small number of lines in each lineage that generally fail to retain the phenotype of the original patient tumour. Here we develop a cell culture medium that enables us to routinely establish cell lines from diverse subtypes of human ovarian cancers with >95% efficiency. Importantly, the 25 new ovarian tumour cell lines described here retain the genomic landscape, histopathology and molecular features of the original tumours. Furthermore, the molecular profile and drug response of these cell lines correlate with distinct groups of primary tumours with different outcomes. Thus, tumour cell lines derived using this methodology represent a significantly improved platform to study human tumour pathophysiology and response to therapy.
目前可用的人类肿瘤细胞系库在每个谱系中仅包含少数细胞系,这些细胞系通常无法保留原始患者肿瘤的表型。在此,我们开发了一种细胞培养基,使我们能够以>95%的效率从人类卵巢癌的不同亚型中常规建立细胞系。重要的是,这里描述的25种新的卵巢肿瘤细胞系保留了原始肿瘤的基因组格局、组织病理学和分子特征。此外,这些细胞系的分子谱和药物反应与具有不同预后的不同原发性肿瘤组相关。因此,使用这种方法衍生的肿瘤细胞系代表了一个显著改进的平台,用于研究人类肿瘤病理生理学和对治疗的反应。